Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01527981 · ClinicalTrials.gov registry record · Phase 2
Cognitive Behavioral Therapy (CBT) for Adherence and Depression in Type 1 Diabetes
A Phase 2 study of Depression and Type 1 Diabetes, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT01527981: Completed Phase 2 study of Depression and Type 1 Diabetes, sponsored by Massachusetts General Hospital.
NCT01527981 is a Phase 2 study of Depression and Type 1 Diabetes that has completed, run by Massachusetts General Hospital. The registered enrollment target is 9 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01527981, a Phase 2 study of Depression and Type 1 Diabetes, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a pilot behavioral intervention trial, designed to initially examine cognitive behavioral therapy for medical adherence and depression (CBT-AD) in patients with depression and poorly controlled type 1 diabetes.
Primary Outcome
We used electronic glucometers to measure participants' adherence to prescribed glucose self-monitoring, which record each time glucose was measured and the glucose level of each measurement.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive behavioral therapy for adherence and depression
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-11 |
| Phase | Phase 2 |
What the finished NCT01527981 record still lists
NCT01527981 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Cognitive behavioral therapy for adherence and depression is the first listed.
NCT01527981 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01527981 about?
NCT01527981 is a clinical study titled "Cognitive Behavioral Therapy (CBT) for Adherence and Depression in Type 1 Diabetes". This study is a pilot behavioral intervention trial, designed to initially examine cognitive behavioral therapy for medical adherence and depression (CBT-AD) in patients with depression and poorly controlled type 1 diabetes.
What is the current status of trial NCT01527981?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2008-03. Estimated completion is 2010-11.
What conditions does trial NCT01527981 study?
This clinical trial studies the following conditions: Depression, Type 1 Diabetes.
What interventions are being tested in trial NCT01527981?
The interventions under investigation include: Cognitive behavioral therapy for adherence and depression (BEHAVIORAL).
Who is sponsoring clinical trial NCT01527981?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01527981 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01527981's enrollment target sits among peer trials
9 664th of 679 higher than 14 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
RECRUITING · Phase 2
-
Neurobiology of Suicide
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia